Michael Fralick

Clinician Scientist @SinaiHealth | amateur golfer/gardener/barista | | | |

[Michael Fralick @FralickMike]

📬 Stay in the Loop with Medicine Pods! Sign up for our monthly newsletter at https://t.co/o2UEGOlgyB to get the latest podcast episodes, medical infographics, and our monthly blog (qMonthly)—delivered straight to your inbox! 📷@InternAtWork @roundstable

[Medicine Pods @MedicinePods]

🩺 New qMonthly is here!

1️⃣ Beta-blockers after MI: No benefit when LVEF ≥50% (HR 0.97)
2️⃣ Spironolactone in dialysis: No CV improvement (HR 0.92; stopped early for futility)

Legacy practices under fire 🔥

#MedTwitter #Cardiology #EvidenceBasedMedicine #Dialysis

[Medicine Pods @MedicinePods]

📢 New Nephro Trial Files!

🩸 Conservative dialysis boosts kidney recovery in AKI
💊 Pravastatin shows no benefit in early ADPKD
📉 Baxdrostat drops SBP by up to 15.7 mmHg in resistant HTN
🔗 https://t.co/p591iaipih

#NephJC #MedTwitter #FOAMed #KidneyTwitter #Nephrology #RCT

[Medicine Pods @MedicinePods]

🔁 Throwback Thursday: Diabetes Trial Files Edition

📌 Intensive glycemic control
📌 Captopril for diabetic nephropathy
📌 CABG/PCI vs. medical therapy in T2DM + CAD

🧵 Read more: https://t.co/1aiUwjXzXM

#Diabetes #Cardiology #Nephrology #FOAMed

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

This week, Dr. @JohnFralick8 breaks down a new RCT comparing rituximab vs conventional therapy for inducing remission in EGPA

#MedTwitter #FOAMed #MedEd #Rheumatology #EGPA #ClinicalTrials

[Medicine Pods @MedicinePods]

📬 Stay in the Loop with Medicine Pods! Sign up for our monthly newsletter at https://t.co/DloH2rHC0L to get the latest podcast episodes and medical infographics, delivered straight to your inbox!

#MedEd #MedTwitter

[Medicine Pods @MedicinePods]

🫁 Confused by ABGs?

@FralickMike's one-pager makes sense of:
✅Metabolic and respiratory acidosis/alkalosis
✅Key compensation patterns

Grab the full book here: https://t.co/Kv9WnYVNn4

#MedTwitter #InternalMedicine

[Medicine Pods @MedicinePods]

🎓 Residents & Royal College candidates, this one's for you:

Unlock your exam success with our new “Royal  College  Resources” page — a curated hub of videos, podcasts & clinical‑practice guideline review.

👉 https://t.co/3l3dY9kuME

#RoyalCollege #MedEd #InternalMedicine

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

This week Dr. @FralickMike is joined by returning guest Dr. Yatin Chadha to talk about his new beyond Radiology online course series!

🧠 CT Head Basics for Clinicians
❓ Artifact or Pathology?

https://t.co/WuyckeQh77

#MedTwitter #MedEd #Radiology

[Medicine Pods @MedicinePods]

🎙️ New @RoundsTable infographics!

🩸 UGIB + Cirrhosis: Shorter/no antibiotics ≈ longer for mortality, slightly ↑ infection risk (JAMA IM 2025)
🫀 Dialysis + Spironolactone: No ↓ in CV death/HF hospitalization (Lancet 2025)

#MedTwitter #FOAMed #MedEd #ClinicalTrials

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

Dr. @FralickMike goes solo this week to unpack a new systematic review & meta-analysis on whether to continue or withhold RAS inhibitors before noncardiac surgery⚖️

#MedTwitter #FOAMed #MedEd #Cardiology #PerioperativeCare #ClinicalTrials

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

We’re back with a Classic Rapid Fire episode! 🔥

Drs. Mike & John Fralick break down two new studies:
💊 Spironolactone in dialysis patients (ACHIEVE Trial)
🩸 Antibiotic prophylaxis for UGIB in cirrhosis

#MedTwitter #MedEd #ClinicalTrials

[Medicine Pods @MedicinePods]

🩸New Heme Onc Trial Files!

📌10-yr data on ibrutinib in CLL (RESONATE-2)
📌Ibrutinib+rituximab > chemo in MCL (ENRICH)
📌ATO+ATRA beats chemo in high-risk APL (APOLLO)

Read more: https://t.co/j0OUnQc1wA

#HemeOnc #OncTwitter #CLL #MCL #APL #MedTwitter #ClinicalTrials #FOAMed

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

Throwback time! ⏪ Dr. @FralickMike and guest Dr. Laiya Carayannopoulos revisit two key studies:

💨 Noninvasive airway management in comatose patients after acute poisoning
💊 PEN-FAST score for low-risk penicillin allergy

#MedTwitter #MedEd

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

Dr. @FralickMike breaks down a new trial comparing spironolactone vs amiloride for resistant hypertension — is amiloride noninferior? Let's find out!

#MedTwitter #FOAMed #MedEd #Cardiology #Hypertension #ClinicalTrials

[Medicine Pods @MedicinePods]

💊 IBD Trial Files Throwback

📸 Early colonoscopy + step-up therapy reduced Crohn’s recurrence post-surgery
🧪 Infliximab + azathioprine > either alone in SONIC

Read now: https://t.co/g8zB9EIlLf

#Crohns #MedTwitter #FOAMed #Gastroenterology

[Medicine Pods @MedicinePods]

🩸 Heme Onc Throwback Thursday

💊 Imatinib beat interferon in CML (87% vs 35% response)
🧬 Ruxolitinib outperformed BAT in PV (78% hematocrit control)
🔥 Midostaurin improved survival in FLT3-mutated AML

Read now: https://t.co/azzxJAmsvt

#HemeOnc #MedTwitter #Oncology

[Michael Fralick @FralickMike]

A new one pager on CKD. Feedback welcomed! Thank you to everyone who has provided feedback on earlier versions of it!

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners,

Solo ep with @FralickMike! He reviews a new trial of aspirin in patients with chronic coronary syndrome on oral anticoagulation.

#MedTwitter #Cardiology

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners: Hot off #ESC2025 Drs. @FralickMike & @JohnFralick8 break down K+ for arrhythmias, digitoxin in HFrEF, RSV vax, & apixaban for VTE in this Rapid Fire episode.

[Dr Mark Silverberg @guthealthmd]

IBD Trial Files (https://t.co/4pMSzYALTw) is a free monthly email newsletter that uses AI to find and summarize practice-changing randomized controlled trials in Inflammatory Bowel Disease. The newsletter helps medical trainees and physicians stay up-to-date on the latest advances in IBD research and treatment. Each edition features concise, clinically relevant trial summaries to keep you informed. Visit https://t.co/mAqwnwat61 (https://t.co/4pMSzYALTw) to check it out and subscribe. @zanegallinger @fralickmike @kat_zorcic